IL5 and schizophrenia: ∙ Following two months of treatment, Positive and Negative Symptom Scale (PANSS) scores and IL-5 levels in patients withfirst-episode schizophrenia decreased significantly, suggesting that theelevation in IL-5 is more likely attributable to the disease itself rather thanmedication effects.